Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
DIH Holdings US, Inc. Class A Common Stock (DHAI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/25/2025: DHAI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -16.25% | Avg. Invested days 38 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/25/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.88M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.03 | 52 Weeks Range 0.12 - 3.67 | Updated Date 06/29/2025 |
52 Weeks Range 0.12 - 3.67 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.79% | Operating Margin (TTM) -17.49% |
Management Effectiveness
Return on Assets (TTM) -4.63% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 26684334 | Price to Sales(TTM) 0.17 |
Enterprise Value 26684334 | Price to Sales(TTM) 0.17 | ||
Enterprise Value to Revenue 0.41 | Enterprise Value to EBITDA - | Shares Outstanding 47336300 | Shares Floating 15773934 |
Shares Outstanding 47336300 | Shares Floating 15773934 | ||
Percent Insiders 50.42 | Percent Institutions 12.13 |
Upturn AI SWOT
DIH Holdings US, Inc. Class A Common Stock
Company Overview
History and Background
DIH Holdings US, Inc. is a global med-tech company combining innovative rehabilitation robotics and virtual reality solutions. Its origins stem from integrating advanced technologies to enhance patient recovery and outcomes.
Core Business Areas
- Rehabilitation Robotics: Develops and markets robotic devices for rehabilitation, improving patient motor skills and functional independence.
- Virtual Reality Rehabilitation: Offers virtual reality-based rehabilitation programs to enhance patient engagement and outcomes through immersive training.
- Clinical Solutions and Services: Provides clinical services and integrated rehabilitation solutions to hospitals and rehabilitation centers.
Leadership and Structure
Information on DIH Holdings US, Inc.'s leadership team and organizational structure is not readily available in detail.
Top Products and Market Share
Key Offerings
- Motus Nova: Robotic rehabilitation device focusing on hand and upper extremity rehabilitation. Market share data is not readily available. Competitors include ReWalk Robotics and Hocoma.
- VR Free: Virtual reality rehabilitation system for improving motor and cognitive function. Market share data is not readily available. Competitors include MindMaze and XRHealth.
Market Dynamics
Industry Overview
The rehabilitation technology market is growing due to aging populations, increasing prevalence of neurological disorders, and advancements in robotics and virtual reality.
Positioning
DIH Holdings US, Inc. aims to be a leader in integrated rehabilitation solutions, leveraging robotics and VR technologies to improve patient outcomes. Competitive advantage lies in its broad portfolio of rehabilitation technology.
Total Addressable Market (TAM)
The global rehabilitation robotics market is projected to reach billions of dollars. DIH Holdings US, Inc. is positioned to capture a portion of this TAM through its product offerings and strategic partnerships. Specific TAM data and company share of it are unavailable publicly.
Upturn SWOT Analysis
Strengths
- Comprehensive product portfolio
- Innovative technology in robotics and VR
- Global presence
- Focus on integrated rehabilitation solutions
Weaknesses
- Limited financial resources compared to larger competitors
- Dependence on technology adoption in healthcare
- Complex regulatory environment
- Marketing is not as strong as some competitors
Opportunities
- Expanding into new geographic markets
- Developing new rehabilitation applications for existing technologies
- Forming strategic partnerships with healthcare providers
- Capitalizing on the growing demand for telerehabilitation
Threats
- Intense competition from established medical device companies
- Reimbursement challenges from healthcare payers
- Technological obsolescence
- Economic downturn affecting healthcare spending
Competitors and Market Share
Key Competitors
- ReWalk Robotics (RWLK)
- Ekso Bionics Holdings, Inc. (EKSO)
- Hocoma (Private)
- MindMaze (Private)
- XRHealth (Private)
Competitive Landscape
DIH Holdings US, Inc. competes with both established medical device companies and smaller, specialized robotics and VR firms. They leverage innovative technology as an edge, but they will need to continue to innovate as the market matures and becomes even more competitive.
Major Acquisitions
Lunexis B.V.
- Year: 2021
- Acquisition Price (USD millions): 2.9
- Strategic Rationale: Expansion of Rehabilitation Robotics Portfolio and new geographic region, Netherlands
Growth Trajectory and Initiatives
Historical Growth: Unavailable due to the lack of readily available data.
Future Projections: Unavailable due to the lack of readily available analyst estimates.
Recent Initiatives: Recent initiatives likely include product development, market expansion, and strategic partnerships, but specific details are not widely publicized.
Summary
DIH Holdings US, Inc. has a decent position in the rehabilitation technology market with its focus on robotics and VR. Its innovative solutions provide a competitive edge but needs to ensure it focuses on continuing innovations and improving its technology adoption as the market becomes more competitive. Its lack of financial data may present transparency issues that may make investing in the company difficult. They should strive to expand into new geographic markets and form partnerships, but they need to protect themselves from the economic downturns and intense competition from more established companies.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Market Research Reports
- Public Filings (if available)
Disclaimers:
The information provided is based on publicly available sources and may not be entirely comprehensive or accurate. Market share data is estimated and may vary. This analysis is for informational purposes only and does not constitute investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DIH Holdings US, Inc. Class A Common Stock
Exchange NASDAQ | Headquaters Norwell, MA, United States | ||
IPO Launch date 2022-03-21 | Founder, Chairman & CEO Mr. Jason Chen | ||
Sector Healthcare | Industry Medical Devices | Full time employees - | Website https://www.dih.com |
Full time employees - | Website https://www.dih.com | ||
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.